A detailed history of Sky Oak Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sky Oak Wealth, LLC holds 6,442 shares of ABBV stock, worth $1.1 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
6,442
Previous 10,854 40.65%
Holding current value
$1.1 Million
Previous $1.68 Million 30.26%
% of portfolio
0.28%
Previous 0.44%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$159.82 - $182.1 $705,125 - $803,425
-4,412 Reduced 40.65%
6,442 $1.17 Million
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $137,600 - $154,970
1,000 Added 10.15%
10,854 $1.68 Million
Q3 2023

Oct 24, 2023

SELL
$133.59 - $154.65 $8,416 - $9,742
-63 Reduced 0.64%
9,854 $1.47 Million
Q2 2023

Jul 20, 2023

SELL
$132.51 - $164.9 $92,757 - $115,430
-700 Reduced 6.59%
9,917 $1.34 Million
Q1 2023

May 02, 2023

BUY
$144.61 - $166.54 $101,227 - $116,578
700 Added 7.06%
10,617 $1.69 Million
Q4 2022

Jan 26, 2023

SELL
$138.31 - $165.87 $41,493 - $49,761
-300 Reduced 2.94%
9,917 $0
Q3 2022

Oct 25, 2022

BUY
$134.21 - $153.93 $67,105 - $76,965
500 Added 5.15%
10,217 $1.37 Million
Q2 2022

Jul 26, 2022

BUY
$137.62 - $174.96 $10,046 - $12,772
73 Added 0.76%
9,717 $1.49 Million
Q4 2021

Jan 24, 2022

BUY
$107.43 - $135.93 $448,197 - $567,099
4,172 Added 76.24%
9,644 $1.31 Million
Q2 2021

Jul 19, 2021

SELL
$105.21 - $117.21 $26,302 - $29,302
-250 Reduced 4.37%
5,472 $616,000
Q1 2021

Apr 29, 2021

BUY
$102.3 - $112.62 $132,990 - $146,406
1,300 Added 29.4%
5,722 $640,000
Q4 2020

Feb 02, 2021

SELL
$80.49 - $108.67 $3,058 - $4,129
-38 Reduced 0.85%
4,422 $474,000
Q2 2020

Aug 10, 2020

BUY
$73.37 - $98.18 $83,054 - $111,139
1,132 Added 34.01%
4,460 $438,000
Q1 2020

May 04, 2020

SELL
$64.5 - $97.79 $77,787 - $117,934
-1,206 Reduced 26.6%
3,328 $254,000
Q4 2019

Feb 04, 2020

BUY
$72.13 - $90.25 $327,037 - $409,193
4,534 New
4,534 $401,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sky Oak Wealth, LLC Portfolio

Follow Sky Oak Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sky Oak Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sky Oak Wealth, LLC with notifications on news.